Gregory D. Perry - Feb 25, 2022 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Chief Financial Officer
Signature
/s/ Trey Reilly, Attorney-in-Fact
Stock symbol
FNCH
Transactions as of
Feb 25, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 05:50 PM
Previous filing
Jun 21, 2021
Next filing
Jun 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FNCH Employee Stock Option (right to buy) Award $0 +80K $0.00 80K Feb 25, 2022 Common Stock 80K $8.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a four-year period commencing on February 1, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.